Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology


Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.

https://media-www.fapvoice.com/wp-content/uploads/2016/08/1.jpg

expertly curated content related to this topic